Pulse oximetry is a widely accepted noninvasive procedure for measuring the oxygen saturation level of arterial blood, an indicator of a person's oxygen supply. A typical pulse oximetry system utilizes an optical sensor attached to a fingertip to measure the relative volume of oxygenated hemoglobin in pulsatile arterial blood flowing within the fingertip. Oxygen saturation (SpO2), pulse rate and a plethysmograph waveform, which is a visualization of pulsatile blood flow over time, are displayed on a monitor accordingly.
Conventional pulse oximetry assumes that arterial blood is the only pulsatile blood flow in the measurement site. During patient motion, venous blood also moves, which causes errors in conventional pulse oximetry. Advanced pulse oximetry processes the venous blood signal so as to report true arterial oxygen saturation and pulse rate under conditions of patient movement. Advanced pulse oximetry also functions under conditions of low perfusion (small signal amplitude), intense ambient light (artificial or sunlight) and electrosurgical instrument interference, which are scenarios where conventional pulse oximetry tends to fail.
Advanced pulse oximetry is described in at least U.S. Pat. Nos. 6,770,028; 6,658,276; 6,157,850; 6,002,952; 5,769,785 and 5,758,644, which are assigned to Masimo Corporation (“Masimo”) of Irvine, Calif. and are incorporated in their entirety by reference herein. Corresponding low noise optical sensors are disclosed in at least U.S. Pat. Nos. 6,985,764; 6,813,511; 6,792,300; 6,256,523; 6,088,607; 5,782,757 and 5,638,818, which are also assigned to Masimo and are also incorporated in their entirety by reference herein. Advanced pulse oximetry systems including Masimo SET® low noise optical sensors and read through motion pulse oximetry monitors for measuring SpO2, pulse rate (PR) and perfusion index (PI) are available from Masimo. Optical sensors include any of Masimo LNOP®, LNCS®, SofTouch™ and BIue™ adhesive or reusable sensors. Pulse oximetry monitors include any of Masimo Rad-8®, Rad-5®, Rad®-5v or SatShare® monitors.
Advanced blood parameter measurement systems are described in at least U.S. Pat. No. 7,647,083, filed Mar. 1, 2006, titled Multiple Wavelength Sensor Equalization; U.S. Pat. No. 7,729,733, filed Mar. 1, 2006, titled Configurable Physiological Measurement System; U.S. Pat. Pub. No. 2006/0211925, filed Mar. 1, 2006, titled Physiological Parameter Confidence Measure and U.S. Pat. Pub. No. 2006/0238358, filed Mar. 1, 2006, titled Noninvasive Multi-Parameter Patient Monitor, all assigned to Cercacor Laboratories, Inc., Irvine, Calif. (Cercacor) and all incorporated in their entirety by reference herein. Advanced blood parameter measurement systems include Masimo Rainbow® SET, which provides measurements in addition to SpO2, such as total hemoglobin (SpHb™), oxygen content (SpOC™), methemoglobin (SpMet®), carboxyhemoglobin (SpCO®) and PVI®. Advanced blood parameter sensors include Masimo Rainbow® adhesive, ReSposable™ and reusable sensors. Advanced blood parameter monitors include Masimo Radical-7™, Rad87™ and Rad57™, Pronto-7® and Pronto® monitors, all available from Masimo. Such advanced pulse oximeters, low noise sensors and advanced blood parameter systems have gained rapid acceptance in a wide variety of medical applications, including surgical wards, intensive care and neonatal units, general wards, home care, physical training, and virtually all types of monitoring scenarios.
A physiological monitor gauge panel displays a graphical user interface (GUI) that allows medical care providers to quickly view and immediately and intuitively recognize and assess patient status across multiple parameters. The GUI comprises multiple gauges arranged in a panel. In an embodiment, a face of each gauge is configured as a circular portion. A needle of each gauge rotatably moves across the gauge face so as to indicate a parameter value. A gauge readout integrated with the gauge face also indicates a parameter value. An alarm region is disposed along at least one end of the face so as to indicate a lower alarm limit, an upper alarm limit or both lower and upper alarm limits. The alarm region becomes brightly illuminated when the needle is within the alarm region so as to alert a caregiver of an alarm condition.
In an embodiment, the physiological monitor gauge has a gauge face with generally semi-circular upper and lower edges defining downward-oriented ends and a mid-point between the ends defining an arced peak. Positions along the gauge face correspond to physiological parameter values. An indicator is disposed on the gauge face and is moveable along the gauge face according to a parameter value. The parameter value is displayed as at least one digit underneath the arced peak. The parameter type is specified under the parameter value.
One aspect of a physiological monitor gauge panel has a gauge face with generally semi-circular upper and lower edges. Each edge has downward-oriented ends and a mid-point defining an arced peak. Positions along the gauge face correspond to parameter values. An indicator is disposed on the gauge face and is moveable along the gauge face according to parameter values. At least one digit is displayed underneath the arced peak according to parameter values, and a parameter type is displayed under the at least one digit. In various embodiments, a generally arced color bar is disposed along the gauge face proximate at least one of the ends. The color bar defines an alarm region for parameter values. An arced histogram is disposed above the gauge face upper edge having bins, each of which generally represent parameter values corresponding to bin positions along the gauge face. Bin fills are depicted as relatively dark lines of various lengths coextending with particular ones of the bins. The bin fills each depict the amount of time the indicator persists at a given parameter value associated with a bin position.
Further aspect of a physiological monitor gauge panel are an alarm condition corresponding to the indicator positioned over the color bar. The gauge face changes from a generally neutral color to a red color during the alarm condition. Parameter value digits change from a black color to a white color during the alarm condition, and a background of the parameter value changes to a generally red color. A ghost face represents an unused quarter-circle region proximate one of the gauge face ends. A second generally arced color bar is located proximate the color bar and defines a cautionary region for parameter values. Gauge faces and corresponding indicators, parameter values and parameter types define a panel of parameter gauges. The indicators of each parameter gauge are generally centered at each of the arced peaks of the gauge faces so as to designate generally nominal values for the underlying physiological parameters. The panel displaying one or more significantly off-centered indicators signifies a potentially significant physiological event.
Another aspect of a physiological monitor gauge panel defines parameters to display on a physiological monitor via corresponding gauges. Gauge faces depict a range of parameter values for each of the parameters. An indicator designates a position on each gauge face corresponding to the current parameter value within the range of parameter values. The indicated position on each of the gauges is at the mid-point of each of the gauge faces when each of the parameters is at a nominal value. In various embodiments, gauge faces define a semi-circular range for each parameter. A low-range gauge has a left quarter-circle active face portion and a right quarter-circle inactive face portion. A high-range gauge has a right quarter-circle active face portion and a left quarter-circle inactive face portion. A high/low-range gauge has both a right quarter-circle active face portion and a left quarter-circle active face portion. A color bar designates an alarm region of parameter values. A second color bar designates a cautionary region of parameter values.
Yet another aspect of a physiological monitor gauge is a gauge face for depicting a range of values of a parameter on a physiological monitor. An indicator rotatably moves along the gauge face in response to the parameter so as to designate a current value for the parameter. The gauge face is configured so that the indicator is centered on the gauge face when the parameter current value is a nominal value. In various embodiments, the gauge face has a left-sided active face when the parameter has alarm limits for only low parameter values and a right-sided active face when the parameter has alarm limits for only high parameter values. The gauge face has both a left-sided active face and a right-sided active face when the parameter has alarm limits for both low parameter values and high parameter values. An active histogram is disposed proximate the active face for indicating the amount of time the indicator persists at a given parameter value. A virtual sliding knob sets the alarm limits along the gauge face.
An exemplar gauge panel configuration displays three half-circle gauges including a SpO2 (oxygen saturation) gauge 101, a SpHb (total hemoglobin) gauge 102 and a SpMet (methemoglobin) gauge 103. Each gauge has a semi-circular face 110 and a parameter value indicator 120 that rotatably travels along each face 110. In particular, each indicator 120 is a visible tip terminating an apparent (unseen) needle that extends from, and rotatably pivots around, a gauge center. See, e.g.,
As shown in
Also shown in
Further shown in
Additionally shown in
A physiological monitor gauge panel has been disclosed in detail in connection with various embodiments. These embodiments are disclosed by way of examples only and are not to be construed as limiting the scope of the claims that follow. One of ordinary skill in the art will appreciate many variations and modifications.
Embodiments of the present disclosure include a portable or other multi-parameter patient monitor capable of determining multiple physiological parameters from one or more signals output from one or more light sensitive detectors capable of detecting light attenuated by body tissue carrying pulsing blood. For example, in an embodiment, the monitor advantageously and accurately determines a wide variety of physiological parameters or other calculations as discussed above.
In an embodiment, the display of patient monitor advantageously includes a plurality of display modes enabling more parameter data to be displayed than the available physical display real estate. For example, the patient monitor may include one or more user input keys capable of toggling through measurement data. In an embodiment, the displays include mode indicators providing caregivers easily identifiable visual queues, such as LED's, text, icons, or other indicia providing readily identifiable queues as to which parameter is being displayed. In an embodiment, the display may shift, may be parameter color-coded, or the like to further ensure quick comprehension of which measured parameter is the displayed parameter. For example, in an embodiment, the monitor displays SpO2 in white, pulse rate (BPM) in green, HbCO in orange, and HbMet in blue when the respective measured parameter is within a “normal” range.
In an embodiment, the patient monitor provides an indication that the caregiver should change display modes to view more critical or time sensitive measured parameters, specific caregiver selected parameters, or the like. For example, the patient monitor may advantageously sound audio or visual alarms that alert the caregiver to particular one or more of worsening parameters, parameters changing in a predetermined pattern or rate, parameters stabilizing below user defined or safe thresholds, caregiver selected parameters, or the like. The monitor may also use alerts that provide audio or visual indications of the severity of the condition, severity of the change, or the like. In alternative embodiments, the patient monitor may automatically change display modes when a particular parameter crosses one or more thresholds. For example, a patient monitor may be displaying a first parameter, such as a plethysmograph, and upon determining measurements indicating that HBMet is trending toward an alarm condition, the monitor may automatically switch from displaying the first parameter to the alarming parameter, or in this case, a trend of the alarming parameter.
In an embodiment, a switch is provided to allow a user to switch displays to view an alarming measurement. In an embodiment, during an alarm condition, a parameter display may switch to a trend graph in the same or different color, line weight, flash, flash rate, intensity, size, or the like.
The patient monitor may also include one or more displays capable of displaying trend data for any one or more of the monitored or derived patient parameters. For example, the trend data may be displayed in graph form, may include multiple trend lines, each representing a different monitored or derived patient parameter. Moreover, each trend line may be color-coded to facilitate quick comprehension of which trend line represents which measured parameter. However, an artisan will recognize from the disclosure herein a large number of identification techniques including color-coding, identifying text, or the like. Additionally, user input may toggle displayed trend data, may select which parameters to display simultaneously, or the like.
In an embodiment, the patient monitor includes an audible or visual indication of a type of sensor communicating with the monitor. For example, the patient monitor may provide a particular audio or visual indication, such as a beep, LED activation, graphic activation, text messages, voice messages, or the like, to indicate communication with or connection to an approved sensor, patient cable, combination, or the like. In an embodiment, the indication may change based on the manufacturer, type of sensor recognized or not recognized, type of patient, type of physiological parameters measurable with the attached sensor, or the like. Additional embodiments include an indication of perfusion in the tissue of the measurement site and an indication of the confidence the signal processing has in its output measurements or input signal quality.
To facilitate an understanding of the disclosure, the remainder of the description references exemplary embodiments illustrated in the drawings. Moreover, in this application, reference is made to many blood parameters. Some references that have common shorthand designations are referenced through such shorthand designations. For example, as used herein, HbCO designates carboxyhemoglobin, HbMet designates methemoglobin, and Hbt designates total hemoglobin. Other shorthand designations such as COHb, MetHb, and tHb are also common in the art for these same constituents. These constituents are generally reported herein in terms of a percentage, often referred to as saturation, relative concentration or fractional saturation. Total hemoglobin is generally reported as a concentration in g/dL. The use of the particular shorthand designators presented in this application does not restrict the term to any particular manner in which the designated constituent is reported.
In an embodiment, the sensor interface 1110 manages communication with external computing devices. For example, in an embodiment, a multipurpose sensor port (or input/output port) is capable of connecting to the sensor 1106 or alternatively connecting to a computing device, such as a personal computer, a PDA, additional monitoring equipment or networks, or the like. When connected to the computing device, the processing board 1104 may upload various stored data for, for example, off-line analysis and diagnosis. The stored data may comprise trend data for any one or more of the measured parameter data, plethysmograph waveform data acoustic sound waveform, or the like. Moreover, the processing board 1104 may advantageously download from the computing device various upgrades or executable programs, may perform diagnosis on the hardware or software of the monitor 1102. In addition, the processing board 1104 may advantageously be used to view and examine patient data, including raw data, at or away from a monitoring site, through data uploads/downloads, or network connections, combinations, or the like, such as for customer support purposes including software maintenance, customer technical support, and the like. Upgradable sensor ports are disclosed in copending U.S. application Ser. No. 10/898,680, filed on Jul. 23, 2004, titled “Multipurpose Sensor Port”.
As shown in
The sensor 1106 may comprise a reusable clip-type sensor, a disposable adhesive-type sensor, a combination sensor having reusable and disposable components, or the like. Moreover, an artisan will recognize from the disclosure herein that the sensor 1106 can also comprise mechanical structures, adhesive or other tape structures, Velcro wraps or combination structures specialized for the type of patient, type of monitoring, type of monitor, or the like. In an embodiment, the sensor 1106 provides data to the board 1104 and vice versa through, for example, a patient cable. An artisan will also recognize from the disclosure herein that such communication can be wireless, over public or private networks or computing systems or devices, or the like.
As shown in
The memory 1122 may advantageous store some or all of a wide variety data and information, including, for example, information on the type or operation of the sensor 1106; type or identification of sensor buyer or distributor or groups of buyer or distributors, sensor manufacturer information, sensor characteristics including the number of emitting devices, the number of emission wavelengths, data relating to emission centroids, data relating to a change in emission characteristics based on varying temperature, history of the sensor temperature, current, or voltage, emitter specifications, emitter drive requirements, demodulation data, calculation mode data, the parameters for which the sensor is capable of supplying sufficient measurement data (e.g., HpCO, HpMet, HbT, or the like), calibration or parameter coefficient data, software such as scripts, executable code, or the like, sensor electronic elements, whether the sensor is a disposable, reusable, multi-site, partially reusable, partially disposable sensor, whether it is an adhesive or non-adhesive sensor, whether the sensor is a reflectance, transmittance, or transreflectance sensor, whether the sensor is a finger, hand, foot, forehead, or ear sensor, whether the sensor is a stereo sensor or a two-headed sensor, sensor life data indicating whether some or all sensor components have expired and should be replaced, encryption information, keys, indexes to keys or hash functions, or the like, monitor or algorithm upgrade instructions or data, some or all of parameter equations, information about the patient, age, sex, medications, and other information that may be useful for the accuracy or alarm settings and sensitivities, trend history, alarm history, or the like. In an embodiment, the monitor may advantageously store data on the memory device, including, for example, measured trending data for any number of parameters for any number of patients, or the like, sensor use or expiration calculations, sensor history, or the like.
In still additional embodiments, the host instrument 1108 includes audio or visual alarms that alert caregivers that one or more physiological parameters are falling below predetermined safe thresholds. The host instrument 1108 may include indications of the confidence a caregiver should have in the displayed data. In a further embodiment, the host instrument 1108 may advantageously include circuitry capable of determining the expiration or overuse of components of the sensor 1106, including, for example, reusable elements, disposable elements, or combinations of the same.
Although described in terms of certain embodiments, other embodiments or combination of embodiments will be apparent to those of ordinary skill in the art from the disclosure herein. For example, the monitor 1102 may comprise one or more monitoring systems monitoring parameters, such as, for example, vital signs, blood pressure, ECG or EKG, respiration, glucose, bilirubin, or the like. Such systems may combine other information with intensity-derived information to influence diagnosis or device operation. Moreover, the monitor 1102 may advantageously include an audio system, preferably comprising a high quality audio processor and high quality speakers to provide for voiced alarms, messaging, or the like. In an embodiment, the monitor 1102 may advantageously include an audio out jack, conventional audio jacks, headphone jacks, or the like, such that any of the display information disclosed herein may be audiblized for a listener. For example, the monitor 1102 may include an audible transducer input (such as a microphone, piezoelectric sensor, or the like) for collecting one or more of heart sounds, lung sounds, trachea sounds, or other body sounds and such sounds may be reproduced through the audio system and output from the monitor 1102. Also, wired or wireless communications (such as Bluetooth or WiFi, including IEEE 801.11a, b, or g), mobile communications, combinations of the same, or the like, may be used to transmit the audio output to other audio transducers separate from the monitor 1102.
For example, patterns or changes in the continuous noninvasive monitoring of intensity-derived information may cause the activation of other vital sign measurement devices, such as, for example, blood pressure cuffs.
The monitor 1200 also comprises a HbCO indicator 1204 advantageously providing a visual queue that a HbCO capable sensor is properly connected through the connector 1202. For example, the HbCO indicator 1204 may advantageously activate when a sensor is connected that communicates sufficient information to determine HbCO, such as, for example, a sensor capable of emitting sufficient different wavelengths of light, a sensor storing sufficient data on the memory 1122, a sensor having appropriate encryption data or key, combinations of the same, or the like. For example, in an embodiment, the processor 1112 may receive information from a memory 1122 indicating a number of available LED wavelengths for the attached sensor. Based on the number of wavelengths, or other information stored on the memory 1122, the processor 1112 may determine whether an HbCO-ready sensor has been attached to the monitor 1200. An artisan will also recognize from the disclosure herein that the HbCO indicator 1204 may advantageously comprise a HbMet indicator, Hbt indicator, or the like, which activates to a predetermined color associated with a parameter, or any color, or deactivates the same, to convey a type of attached sensor. Moreover, the artisan will recognize from the disclosure herein other parameters that may use other sensor components and the monitor 1200 may include indicators capable of indicating communication with those types of sensors.
In an embodiment, the monitor 1200 may also audibly indicate the type of sensor connected. For example, the monitor 1200 may emit predetermined number or frequency of beeps associated with recognition of a particular sensor, a particular manufacturer, failure to recognize the sensor, or the like. Moreover, the sensor type may be indicative of the componentry, such as, for example, whether the sensor produces sufficient data for the determination of HbCO, HbMet, Hbt and SpO2, SpO2 only, SpO2 and HbMet, any combination of the foregoing or other parameters, or the like. Additionally, the sensor type may be indicative of specific sensors designed for a type of patient, type of patient tissue, or the like. In other embodiments, the monitor 1200 may announce the type of connector through speaker 1236.
An artisan will also recognize from the disclosure herein that other mechanical (such as keys), electrical, or combination devices may inform the monitor 1200 of the type of attached sensor. In an embodiment, the processor 1112 also may select to drive less emitters that are currently available, such as, for example, in the presence of low noise and when power consumption is an issue.
The monitor 1200 also comprises a multi-mode display 1206 capable of displaying, for example, measurements of SpO2 and HbCO (or alternatively, HbMet). In an embodiment, the display 1206 has insufficient space or display real estate to display the many parameters capable of being measured by the monitor 1200. Thus, the multi-mode display 1206 may advantageously cycle through two or more measured parameters in an area common to both parameters even when shifted. In such embodiments, the monitor 1200 may also advantageously include parameter indicators 1208, 1210, providing additional visual queues as to which parameter is currently displayed. In an embodiment, the display may also cycle colors, flash rates, or other audio or visual queues providing readily identifiable information as to which measured parameter is displayed. For example, when the multi-mode display 1206 displays measured values of SpO2 that are normal, the numbers may advantageously appear in green, while normal measured values of HbCO may advantageously appear in orange, and normal measured values of HbMet may appear in blue. Moreover, in an embodiment, the display 1206 flashes at a predefined rate when searching for saturation and at another predefined rate when a signal quality is below a predetermined threshold.
The monitor 1200 also comprises a HbCO bar 1212 where in an embodiment a plurality of LED's activate from a bottom toward a top such that the bar “fills” to a level proportional to the measured value. For example, the bar 1212 is lowest when the dangers from carbon monoxide poisoning are the least, and highest when the dangers are the greatest. The bar 1212 includes indicia 1214 that provide an indication of the severity of carbon monoxide saturation in a patient's blood. As shown in
As is known in the art, carbon monoxide in the blood can lead to serious medical issues. For example and depending upon the particular physiology of a patient, about 10% carbon monoxide saturation can lead to headaches, about 20% can lead to throbbing headaches, or dyspnea on exertion, about 30% can lead to impaired judgment, nausea, dizziness and/or vomiting, visual disturbance, or fatigue, about 40% can lead to confusion and syncope, and about 50% and above can lead to comas, seizures, respiratory failure and even death.
In an embodiment, the bar 1212 is the same or similar color as the multi-mode display 1206 when displaying HbCO. In other embodiments, the bar 1212 is lowest and green when the dangers from carbon monoxide poisoning are the least, and highest and red when the dangers are the greatest. In an embodiment, as HbCO increases, the entire bar 1212 may advantageously change color, such as, for example, from green to red, to provide a clear indication of deepening severity of the condition. In other embodiments, the bar 1212 may advantageously blink or flash, an audio alarm may beep or provide a continuation or rise in pitch or volume, or the like to alert a caregiver of deepening severity. Moreover, straightforward to complex alarm rules may be implemented to reduce false alarms based on, for example, knowledge of the physiological limitations on the rate of change in HbCO or the like.
Additionally, the monitor 1200 may be capable of storing and outputting historical parameter data, display trend traces or data, or the like. Although the foregoing bar 1212 has been described in terms of certain preferred embodiments, other embodiments will be apparent to those of ordinary skill in the art from the disclosure herein.
Activation of the mode/enter button 1222 cycles through various setup menus allowing a caregiver to select or activate certain entries within the menu setup system, including alarm threshold customizations, or the like. Activation of the next button 1224 can move through setup options within the menu setup system and in an embodiment is not active during normal patient monitoring. For example, a caregiver may activate the mode/enter button 1222 and the next button 1224 to specify high and low alarm thresholds for one or more of the measured parameters, to specify device sensitivity, trend settings, display customizations, color code parameters, or the like. In an embodiment, the high alarm setting for SpO2 can range from about two percent (2%) to about one hundred percent (100%) with a granularity of about one percent (1%). The low alarm setting for SpO2 can range from about one percent (1%) to about one hundred percent (100%) with a granularity of about one percent (1%). Moreover, the high alarm setting for pulse rate can range from about thirty (30) BPM to about two hundred and forty (240) BPM with a granularity of about five (5) BPM. The low alarm setting for pulse rate can range from about twenty five (25) BPM to about two hundred and thirty five (235) BPM with a granularity of about five (5) BPM. Other high and low ranges for other measured parameters will be apparent to one of ordinary skill in the art from the disclosure herein.
In a further embodiment, a caregiver may activate the mode/enter button 1222 and the next button 1224 to specify device sensitivity, such as, for example, device averaging times, probe off detection, whether to enable fast saturation calculations, or the like. Various embodiments of fast saturation calculations are disclosed in U.S. patent application Ser. No. 10/213,270, filed Aug. 5, 2002, titled “Variable Indication Estimator”. Using the menus, a caregiver may also advantageously enter appropriate information governing trend collection on one or more of the measured parameters, input signals, or the like.
An artisan will recognize from the disclosure herein that the on/off button 1226 may advantageously cause an electronic determination of whether to operate in at powers consisted with the U.S. (60 Hz) or another nationality (50 Hz). In an embodiment, such automatic determination and switching is removed from the monitor 1200 in order to reduce a likelihood of problematic interfering crosstalk caused by such power switching devices.
Activation of the up/down button 1228 may advantageously adjust the volume of the pulse beep tone. Additionally, activation of the up/down button 1228 within the menu setup system, causes the selection of values with various menu options.
Moreover, activation of the alarm silence button 1230 temporarily silences audio alarms for a predetermined period, such as, for example, about one hundred and twenty (120) seconds. A second activation of the alarm silence button 1230 mutes (suspends) the alarm indefinitely, while a third activation returns the monitor 1200 to standard alarm monitoring.
The monitor 1200 also includes a battery level indicator 1234 indicating remaining battery life. In the illustrated embodiment, four LED's indicate the status of the battery by incrementally deactivating to indicate proportionally decreasing battery life. In an embodiment, the four LED's may also change color as the battery charge decreases, and the final LED may begin to flash to indicate that the caregiver should replace the batteries.
The monitor 1200 also comprises a perfusion quality index (PI™) bar 1240 (which quantifies the measure of perfusion of the patient) where in an embodiment a plurality of LED's activate from a bottom toward a top such that the bar “fills” to a level proportional to the measured value. In one embodiment, the PI™ bar 1240 shows a static value of perfusion for a given time period, such as, for example, one or more pulses. In another embodiment, or functional setting, the PI™ bar 1240 may advantageously pulse with a pulse rate, may hold the last reading and optionally fade until the next reading, may indicate historical readings through colors or fades, or the like. Additionally, the PI™ bar 1240 may advantageously change colors, flash, increasingly flash, or the like to indicate worsening measured values of perfusion.
The PI™ bar 1240 can be used to simply indicate inappropriate occlusion due, for example, to improper attachment of the sensor 1106. The PI™ bar 1240 can also be used as a diagnostic tool during low perfusion for the accurate prediction of illness severity, especially in neonates. Moreover, the rate of change in the PI™ bar 1240 can be indicative of blood loss, sleep arousal, sever hypertension, pain management, the presence or absence of drugs, or the like. According to one embodiment, the PI™ bar 1240 values may comprise a measurement of the signal strength of the arterial pulse as a percentage of the total signal received. For example, in one preferred embodiment, the alternating portion of at least one intensity signal from the sensor 1106 may advantageously be divided by the static portion of the signal. For example, an infrared intensity signal may advantageously be used as it is less subjective to noise.
In an embodiment, a measurement below about 1.25% may indicate medical situations in need of caregiver attention, specifically in monitored neonates. Because of the relevance of about 1.25%, the PI™ bar 1240 may advantageously include level indicia 1242 where the indicia 1242 swap sides of the PI™ bar 1240, thus highlighting any readings below about that threshold. Moreover, behavior of the PI™ bar 1240, as discussed above, may advantageously draw attention to monitored values below such a threshold.
As discussed above, the monitor 1200 may include output functionality that outputs, for example, trend perfusion data, such that a caregiver can monitor measured values of perfusion over time. Alternatively or additionally, the monitor 1200 may display historical trace data on an appropriate display indicating the measured values of perfusion over time. In an embodiment, the trend data is uploaded to an external computing device through, for example, the multipurpose sensor connector 1200 or other input output systems such as USB, serial or parallel ports or the like.
The monitor 1200 also includes an alarm indicator 1244 capable of providing visual queues of the status of one or more of the measured parameters. For example, the alarm indicator 1244 may advantageously be green when all of the measured parameters are within normal conditions, may gradually fade to red, may flash, increasing flash, or the like, as one or more of the measured values approaches or passes predetermined thresholds. In an embodiment, the alarm indicator 1244 activates when any parameter falls below an associated threshold, thereby advantageously informing a caregiver that perhaps a nondisplayed parameters is at an alarm condition. In another embodiment, the alarm indicator 1244 may indicate the status of the parameter displayed on the multi-mode display 1206. In an embodiment, the speaker 1236 may sound in conjunction with and/or in addition to the indicator 1244. Moreover, in an embodiment, an alarming parameter may automatically be displayed, may be emphasized, flashed, colored, combinations of the same or the like to draw a user's attention to the alarming parameter.
Although the foregoing invention has been described in terms of certain preferred embodiments, other embodiments will be apparent to those of ordinary skill in the art from the disclosure herein.
The monitor 1700 also comprises a coarser indication of HbMet through an HbMet bar 1740. In an embodiment, a plurality of LED's activate from a bottom toward a top such that the bar “fills” to a level proportional to the measured value, with increments at about 0.5%, about 1%, about 2%, about 3%, about 4%, about 5%, about 7.5%, about 10%, about 15% and greater than about 20%, although an artisan will recognize from the disclosure herein other useful delineations. Additionally, the HbMet bar 1740 may advantageously change colors, flash, increasingly flash, or the like to indicate worsening measured values of perfusion.
Although disclosed with reference to the HbMet bar 1740, and artisan will recognize from the disclosure herein other coarse or even gross indications of HbMet, or any measured parameter. For example, a single LED may advantageously show green, yellow, and red, to indicate worsening coarse values of HbMet. Alternatively, a single LED may simply light to indicate an alarm or approaching alarm condition.
In an embodiment, the display includes a measured value of SpO2 2002, a measured value of pulse rate 2004 in BPM, a plethysmograph 2006, a measured value of HbCO 2008, a measured value of HbMet 2010, a measured value of a perfusion quality 2012, a measured value of Hbt 2014, and a derived value of fractional saturation “SpaO2” 2016. In an embodiment, SpaO2 comprises HbO2 expressed as a percentage of the four main hemoglobin species, i.e., HbO2, Hb, HbCO, and HbMet.
In an embodiment, one or more of the foregoing parameter includes trending or prediction indicators showing the current trend or prediction for that corresponding parameter. In an embodiment, the indicators may advantageously comprise an up arrow, a down arrow, and a hyphen bar to indicate up trending/prediction, down trending/prediction, or neutral trending/prediction.
Moreover, similar to the disclosure above, the measured value of SpO2 2062 may advantageously toggle to measured values of HbCO, HbMet, Hbt, or the like based on, for example, actuation of user input keys, or the like.
In addition to the foregoing, the display may also include graphical data showing one or more color-coded or other identifying indicia for traces of trend data. Moreover, other graphical presentations may advantageously provide readily identifiable indications of monitored parameters or combinations of monitored parameters of the patient. For example, in an embodiment, the display includes a SpaO2 graph 2072. The SpaO2 graph 2072 plots SpO2 as a function of other blood analytes (1-SpaO2), where SpaO2 comprises HbO2 expressed as a percentage of the four main hemoglobin species, i.e., HbO2, Hb, HbCO, and HbMet. Thus, as shown in
Thus, the SpaO2 graph 2072 provides the caregiver with the ability to recognize that even though the measured value of SpO2 may be within acceptable ranges, there are potentially an unacceptable number of hemoglobin carriers unavailable for carrying oxygen, and that other potential problems may exist, such as, for example, harmful carbon monoxide levels, or the like. In an embodiment, various alarm conditions may cause the graph 2072 to change color, flash, or any combination of alarm indications discussed in the forgoing. Moreover,
An embodiment may also include the monitor 2000 advantageously defining regions of wellness/severity of the monitored patient. For example, because the graph 2072 comprises two dimensions, the monitor 2000 may advantageously define regions where the patient's measured physiological parameters are considered acceptable, regions where the patient is considered at risk, regions where the patient is critical, and the like. For example, one region of acceptability may include a high SpO2 and a low 1-SpaO2, another region of risk may include a high SpO2 and a high 1-SpaO2, and another critical region may include a low SpO2 and a high 1-SpaO2. Moreover, an artisan will recognize from the disclosure herein that different parameters may also be combined to provide readily identifiable indications of patient wellness.
In addition to or as an alternative to the two dimensional SpaO2 graph 2072, the monitor 2000 may also include a three dimensional graph, such as, for example, extending the graph 2072 along the variable of time. In this embodiment, the forgoing regions advantageously become three dimensional surfaces of wellness. Moreover, trend data may also be advantageously added to the surface to provide a history of when particular monitored parameters dipped in and out of various surfaces of wellness, risk, criticality, or the like. Such trend data could be color-coded, text identified, or the like. An artisan will also recognize that such surfaces may be dynamic. For example, measurements of HbCO>about 5 may dictate that trend data showing SpO2<about 90% should be considered critical; however, measurements of HbCO<about 5 may dictate only SpO2<about 85% would be critical. Again, an artisan will recognize from the disclosure herein other parameter combinations to create a wide variety of wellness/critical regions or surfaces that provide readily available visual or audio indications of patient well being, trigger specific alarms, or the like.
Moreover, the monitor 2000 may advantageously employ enlargement or reorganization of parameter data based on, for example, the severity of the measurement. For example, the monitor 2000 may display values for HbCO in a small portion of the screen or in the background, and when HbCO begins to approach abnormal levels, the small portion may advantageously grown as severity increases, even in some embodiments to dominate the display. Such visual alarming can be combined with audio alarms such as announcements, alarms, rising frequencies, or the like, and other visual alarms such as flashing, coloration, or the like to assist a caregiver in noticing the increasing severity of a monitored parameter. In an embodiment, a location of the display of an alarming value is changed to be displayed in a larger display area, such as 2002, so as to be readily noticeable and its display values readily ascertainable.
Although the foregoing invention has been described in terms of certain preferred embodiments, other embodiments will be apparent to those of ordinary skill in the art from the disclosure herein. For example, the monitor 1102 may advantageously be adapted to monitor or be included in a monitor capable of measuring physiological parameters other than those determined through absorption spectroscopy, such as, for example, blood pressure, ECG, EKG, respiratory rates, volumes, inputs for blood pressure sensors, acoustical sensors, and the like. Moreover, the monitor 1102 may be adapted for wireless communication to and from the sensor 1106, and/or to and from other monitoring devices, such as, for example, multi-parameter or legacy monitoring devices.
The present application is a continuation of U.S. patent application Ser. No. 13/663,457, filed Oct. 29, 2012, titled Physiological Monitor Gauge Panel, which claims priority benefit under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 61/552,427, filed Oct. 27, 2011, titled Physiological Monitor Gauge Panel; the above-cited applications hereby incorporated in their entirety by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
4300548 | Jones | Nov 1981 | A |
4960128 | Gordon et al. | Oct 1990 | A |
4964408 | Hink et al. | Oct 1990 | A |
5041187 | Hink et al. | Aug 1991 | A |
5069213 | Polczynski | Dec 1991 | A |
5163438 | Gordon et al. | Nov 1992 | A |
5319355 | Russek | Jun 1994 | A |
5337744 | Branigan | Aug 1994 | A |
5341805 | Stavridi et al. | Aug 1994 | A |
D353195 | Savage et al. | Dec 1994 | S |
D353196 | Savage et al. | Dec 1994 | S |
5377676 | Vari et al. | Jan 1995 | A |
D359546 | Savage et al. | Jun 1995 | S |
5431170 | Mathews | Jul 1995 | A |
D361840 | Savage et al. | Aug 1995 | S |
D362063 | Savage et al. | Sep 1995 | S |
5452717 | Branigan et al. | Sep 1995 | A |
D363120 | Savage et al. | Oct 1995 | S |
5456252 | Vari et al. | Oct 1995 | A |
5479934 | Imran | Jan 1996 | A |
5482036 | Diab et al. | Jan 1996 | A |
5490505 | Diab et al. | Feb 1996 | A |
5494043 | O'Sullivan et al. | Feb 1996 | A |
5533511 | Kaspari et al. | Jul 1996 | A |
5534851 | Russek | Jul 1996 | A |
5561275 | Savage et al. | Oct 1996 | A |
5562002 | Lalin | Oct 1996 | A |
5590649 | Caro et al. | Jan 1997 | A |
5602924 | Durand et al. | Feb 1997 | A |
5632272 | Diab et al. | May 1997 | A |
5638816 | Kiani-Azarbayjany et al. | Jun 1997 | A |
5638818 | Diab et al. | Jun 1997 | A |
5645440 | Tobler et al. | Jul 1997 | A |
5685299 | Diab et al. | Nov 1997 | A |
D393830 | Tobler et al. | Apr 1998 | S |
5743262 | Lepper, Jr. et al. | Apr 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5760910 | Lepper, Jr. et al. | Jun 1998 | A |
5769785 | Diab et al. | Jun 1998 | A |
5782757 | Diab et al. | Jul 1998 | A |
5785659 | Caro et al. | Jul 1998 | A |
5791347 | Flaherty et al. | Aug 1998 | A |
5810734 | Caro et al. | Sep 1998 | A |
5823950 | Diab et al. | Oct 1998 | A |
5830131 | Caro et al. | Nov 1998 | A |
5833618 | Caro et al. | Nov 1998 | A |
5860919 | Kiani-Azarbayjany et al. | Jan 1999 | A |
5890929 | Mills et al. | Apr 1999 | A |
5904654 | Wohltmann et al. | May 1999 | A |
5919134 | Diab | Jul 1999 | A |
5934925 | Tobler et al. | Aug 1999 | A |
5940182 | Lepper, Jr. et al. | Aug 1999 | A |
5987343 | Kinast | Nov 1999 | A |
5995855 | Kiani et al. | Nov 1999 | A |
5997343 | Mills et al. | Dec 1999 | A |
6002952 | Diab et al. | Dec 1999 | A |
6011986 | Diab et al. | Jan 2000 | A |
6027452 | Flaherty et al. | Feb 2000 | A |
6036642 | Diab et al. | Mar 2000 | A |
6045509 | Caro et al. | Apr 2000 | A |
6067462 | Diab et al. | May 2000 | A |
6081735 | Diab et al. | Jun 2000 | A |
6088607 | Diab et al. | Jul 2000 | A |
6110522 | Lepper, Jr. et al. | Aug 2000 | A |
6124597 | Shehada | Sep 2000 | A |
6128521 | Marro et al. | Oct 2000 | A |
6129675 | Jay | Oct 2000 | A |
6144868 | Parker | Nov 2000 | A |
6151516 | Kiani-Azarbayjany et al. | Nov 2000 | A |
6152754 | Gerhardt et al. | Nov 2000 | A |
6157850 | Diab et al. | Dec 2000 | A |
6165005 | Mills et al. | Dec 2000 | A |
6184521 | Coffin, IV et al. | Feb 2001 | B1 |
6206830 | Diab et al. | Mar 2001 | B1 |
6229856 | Diab et al. | May 2001 | B1 |
6232609 | Snyder et al. | May 2001 | B1 |
6236872 | Diab et al. | May 2001 | B1 |
6241683 | Macklem et al. | Jun 2001 | B1 |
6253097 | Aronow et al. | Jun 2001 | B1 |
6256523 | Diab et al. | Jul 2001 | B1 |
6263222 | Diab et al. | Jul 2001 | B1 |
6278522 | Lepper, Jr. et al. | Aug 2001 | B1 |
6280213 | Tobler et al. | Aug 2001 | B1 |
6285896 | Tobler et al. | Sep 2001 | B1 |
6301493 | Marro et al. | Oct 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6317627 | Ennen et al. | Nov 2001 | B1 |
6321100 | Parker | Nov 2001 | B1 |
6325761 | Jay | Dec 2001 | B1 |
6334065 | Al-Ali et al. | Dec 2001 | B1 |
6343224 | Parker | Jan 2002 | B1 |
6349228 | Kiani et al. | Feb 2002 | B1 |
6360114 | Diab et al. | Mar 2002 | B1 |
6368283 | Xu et al. | Apr 2002 | B1 |
6371921 | Caro et al. | Apr 2002 | B1 |
6377829 | Al-Ali | Apr 2002 | B1 |
6388240 | Schulz et al. | May 2002 | B2 |
6397091 | Diab et al. | May 2002 | B2 |
6430437 | Marro | Aug 2002 | B1 |
6430525 | Weber et al. | Aug 2002 | B1 |
6463311 | Diab | Oct 2002 | B1 |
6470199 | Kopotic et al. | Oct 2002 | B1 |
6501975 | Diab et al. | Dec 2002 | B2 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6515273 | Al-Ali | Feb 2003 | B2 |
6519487 | Parker | Feb 2003 | B1 |
6525386 | Mills et al. | Feb 2003 | B1 |
6526300 | Kiani et al. | Feb 2003 | B1 |
6541756 | Schulz et al. | Apr 2003 | B2 |
6542764 | Al-Ali et al. | Apr 2003 | B1 |
6580086 | Schulz et al. | Jun 2003 | B1 |
6584336 | Ali et al. | Jun 2003 | B1 |
6595316 | Cybulski et al. | Jul 2003 | B2 |
6597932 | Tian et al. | Jul 2003 | B2 |
6597933 | Kiani et al. | Jul 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6632181 | Flaherty et al. | Oct 2003 | B2 |
6639668 | Trepagnier | Oct 2003 | B1 |
6640116 | Diab | Oct 2003 | B2 |
6643530 | Diab et al. | Nov 2003 | B2 |
6650917 | Diab et al. | Nov 2003 | B2 |
6654624 | Diab et al. | Nov 2003 | B2 |
6658276 | Kiani et al. | Dec 2003 | B2 |
6661161 | Lanzo et al. | Dec 2003 | B1 |
6671531 | Al-Ali et al. | Dec 2003 | B2 |
6678543 | Diab et al. | Jan 2004 | B2 |
6684090 | Ali et al. | Jan 2004 | B2 |
6684091 | Parker | Jan 2004 | B2 |
6697656 | Al-Ali | Feb 2004 | B1 |
6697657 | Shehada et al. | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
RE38476 | Diab et al. | Mar 2004 | E |
6699194 | Diab et al. | Mar 2004 | B1 |
6714804 | Al-Ali et al. | Mar 2004 | B2 |
RE38492 | Diab et al. | Apr 2004 | E |
6721582 | Trepagnier et al. | Apr 2004 | B2 |
6721585 | Parker | Apr 2004 | B1 |
6725075 | Al-Ali | Apr 2004 | B2 |
6728560 | Kollias et al. | Apr 2004 | B2 |
6735459 | Parker | May 2004 | B2 |
6745060 | Diab et al. | Jun 2004 | B2 |
6760607 | Al-Ali | Jul 2004 | B2 |
6770028 | Ali et al. | Aug 2004 | B1 |
6771994 | Kiani et al. | Aug 2004 | B2 |
6792300 | Diab et al. | Sep 2004 | B1 |
6813511 | Diab et al. | Nov 2004 | B2 |
6816741 | Diab | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6826419 | Diab et al. | Nov 2004 | B2 |
6830711 | Mills et al. | Dec 2004 | B2 |
6850787 | Weber et al. | Feb 2005 | B2 |
6850788 | Al-Ali | Feb 2005 | B2 |
6852083 | Caro et al. | Feb 2005 | B2 |
6861639 | Al-Ali | Mar 2005 | B2 |
6898452 | Al-Ali et al. | May 2005 | B2 |
6920345 | Al-Ali et al. | Jul 2005 | B2 |
6931268 | Kiani-Azarbayjany et al. | Aug 2005 | B1 |
6934570 | Kiani et al. | Aug 2005 | B2 |
6939305 | Flaherty et al. | Sep 2005 | B2 |
6943348 | Coffin, IV | Sep 2005 | B1 |
6950687 | Al-Ali | Sep 2005 | B2 |
6961598 | Diab | Nov 2005 | B2 |
6970792 | Diab | Nov 2005 | B1 |
6979812 | Al-Ali | Dec 2005 | B2 |
6985764 | Mason et al. | Jan 2006 | B2 |
6993371 | Kiani et al. | Jan 2006 | B2 |
6996427 | Ali et al. | Feb 2006 | B2 |
6999904 | Weber et al. | Feb 2006 | B2 |
7003338 | Weber et al. | Feb 2006 | B2 |
7003339 | Diab et al. | Feb 2006 | B2 |
7015451 | Dalke et al. | Mar 2006 | B2 |
7024233 | Ali et al. | Apr 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
7030749 | Al-Ali | Apr 2006 | B2 |
7039449 | Al-Ali | May 2006 | B2 |
7041060 | Flaherty et al. | May 2006 | B2 |
7044918 | Diab | May 2006 | B2 |
7048687 | Reuss et al. | May 2006 | B1 |
7067893 | Mills et al. | Jun 2006 | B2 |
7096052 | Mason et al. | Aug 2006 | B2 |
7096054 | Abdul-Hafiz et al. | Aug 2006 | B2 |
7132641 | Schulz et al. | Nov 2006 | B2 |
7142901 | Kiani et al. | Nov 2006 | B2 |
7149561 | Diab | Dec 2006 | B2 |
7186966 | Al-Ali | Mar 2007 | B2 |
7190261 | Al-Ali | Mar 2007 | B2 |
7215984 | Diab | May 2007 | B2 |
7215986 | Diab | May 2007 | B2 |
7221971 | Diab | May 2007 | B2 |
7225006 | Al-Ali et al. | May 2007 | B2 |
7225007 | Al-Ali | May 2007 | B2 |
RE39672 | Shehada et al. | Jun 2007 | E |
7239905 | Kiani-Azarbayjany et al. | Jul 2007 | B2 |
7245953 | Parker | Jul 2007 | B1 |
7254429 | Schurman et al. | Aug 2007 | B2 |
7254431 | Al-Ali | Aug 2007 | B2 |
7254433 | Diab et al. | Aug 2007 | B2 |
7254434 | Schulz et al. | Aug 2007 | B2 |
7272425 | Al-Ali | Sep 2007 | B2 |
7274955 | Kiani et al. | Sep 2007 | B2 |
D554263 | Al-Ali | Oct 2007 | S |
7280858 | Al-Ali et al. | Oct 2007 | B2 |
7289835 | Mansfield et al. | Oct 2007 | B2 |
7292883 | De Felice et al. | Nov 2007 | B2 |
7295866 | Al-Ali | Nov 2007 | B2 |
7328053 | Diab et al. | Feb 2008 | B1 |
7332784 | Mills et al. | Feb 2008 | B2 |
7340287 | Mason et al. | Mar 2008 | B2 |
7341559 | Schulz et al. | Mar 2008 | B2 |
7343186 | Lamego et al. | Mar 2008 | B2 |
D566282 | Al-Ali et al. | Apr 2008 | S |
7355512 | Al-Ali | Apr 2008 | B1 |
7356365 | Schurman | Apr 2008 | B2 |
7371981 | Abdul-Hafiz | May 2008 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
7373194 | Weber et al. | May 2008 | B2 |
7376453 | Diab et al. | May 2008 | B1 |
7377794 | Al Ali et al. | May 2008 | B2 |
7377899 | Weber et al. | May 2008 | B2 |
7383070 | Diab et al. | Jun 2008 | B2 |
7415297 | Al-Ali et al. | Aug 2008 | B2 |
7428432 | Ali et al. | Sep 2008 | B2 |
7438683 | Al-Ali et al. | Oct 2008 | B2 |
7440787 | Diab | Oct 2008 | B2 |
7454240 | Diab et al. | Nov 2008 | B2 |
7467002 | Weber et al. | Dec 2008 | B2 |
7469157 | Diab et al. | Dec 2008 | B2 |
7471969 | Diab et al. | Dec 2008 | B2 |
7471971 | Diab et al. | Dec 2008 | B2 |
7483729 | Al-Ali et al. | Jan 2009 | B2 |
7483730 | Diab et al. | Jan 2009 | B2 |
7489958 | Diab et al. | Feb 2009 | B2 |
7496391 | Diab et al. | Feb 2009 | B2 |
7496393 | Diab et al. | Feb 2009 | B2 |
D587657 | Al-Ali et al. | Mar 2009 | S |
7499741 | Diab et al. | Mar 2009 | B2 |
7499835 | Weber et al. | Mar 2009 | B2 |
7500950 | Al-Ali et al. | Mar 2009 | B2 |
7509154 | Diab et al. | Mar 2009 | B2 |
7509494 | Al-Ali | Mar 2009 | B2 |
7510849 | Schurman et al. | Mar 2009 | B2 |
7526328 | Diab et al. | Apr 2009 | B2 |
7530942 | Diab | May 2009 | B1 |
7530949 | Al Ali et al. | May 2009 | B2 |
7530955 | Diab et al. | May 2009 | B2 |
7563110 | Al-Ali et al. | Jul 2009 | B2 |
7596398 | Al-Ali et al. | Sep 2009 | B2 |
7618375 | Flaherty | Nov 2009 | B2 |
D606659 | Kiani et al. | Dec 2009 | S |
7647083 | Al-Ali et al. | Jan 2010 | B2 |
D609193 | Al-Ali et al. | Feb 2010 | S |
D614305 | Al-Ali et al. | Apr 2010 | S |
RE41317 | Parker | May 2010 | E |
7729733 | Al-Ali et al. | Jun 2010 | B2 |
7734320 | Al-Ali | Jun 2010 | B2 |
7761127 | Al-Ali et al. | Jul 2010 | B2 |
7761128 | Al-Ali et al. | Jul 2010 | B2 |
7764982 | Dalke et al. | Jul 2010 | B2 |
D621516 | Kiani et al. | Aug 2010 | S |
7791155 | Diab | Sep 2010 | B2 |
7801581 | Diab | Sep 2010 | B2 |
7822452 | Schurman et al. | Oct 2010 | B2 |
RE41912 | Parker | Nov 2010 | E |
7844313 | Kiani et al. | Nov 2010 | B2 |
7844314 | Al-Ali | Nov 2010 | B2 |
7844315 | Al-Ali | Nov 2010 | B2 |
7865222 | Weber et al. | Jan 2011 | B2 |
7873497 | Weber et al. | Jan 2011 | B2 |
7880606 | Al-Ali | Feb 2011 | B2 |
7880626 | Al-Ali et al. | Feb 2011 | B2 |
7891355 | Al-Ali et al. | Feb 2011 | B2 |
7894868 | Al-Ali et al. | Feb 2011 | B2 |
7899507 | Al-Ali et al. | Mar 2011 | B2 |
7899518 | Trepagnier et al. | Mar 2011 | B2 |
7904132 | Weber et al. | Mar 2011 | B2 |
7909772 | Popov et al. | Mar 2011 | B2 |
7910875 | Al-Ali | Mar 2011 | B2 |
7919713 | Al-Ali et al. | Apr 2011 | B2 |
7937128 | Al-Ali | May 2011 | B2 |
7937129 | Mason et al. | May 2011 | B2 |
7937130 | Diab et al. | May 2011 | B2 |
7941199 | Kiani | May 2011 | B2 |
7951086 | Flaherty et al. | May 2011 | B2 |
7957780 | Lamego et al. | Jun 2011 | B2 |
7962188 | Kiani et al. | Jun 2011 | B2 |
7962190 | Diab et al. | Jun 2011 | B1 |
7976472 | Kiani | Jul 2011 | B2 |
7988637 | Diab | Aug 2011 | B2 |
7990382 | Kiani | Aug 2011 | B2 |
7991446 | Al-Ali et al. | Aug 2011 | B2 |
8000761 | Al-Ali | Aug 2011 | B2 |
8008088 | Bellott et al. | Aug 2011 | B2 |
RE42753 | Kiani-Azarbayjany | Sep 2011 | E |
8019400 | Diab et al. | Sep 2011 | B2 |
8028701 | Al-Ali et al. | Oct 2011 | B2 |
8029765 | Bellott et al. | Oct 2011 | B2 |
8036727 | Schurman et al. | Oct 2011 | B2 |
8036728 | Diab et al. | Oct 2011 | B2 |
8046040 | Ali et al. | Oct 2011 | B2 |
8046041 | Diab et al. | Oct 2011 | B2 |
8046042 | Diab et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8050728 | Al-Ali et al. | Nov 2011 | B2 |
8092379 | Baker, Jr. | Jan 2012 | B2 |
RE43169 | Parker | Feb 2012 | E |
8118620 | Al-Ali et al. | Feb 2012 | B2 |
8126528 | Diab et al. | Feb 2012 | B2 |
8128572 | Diab et al. | Mar 2012 | B2 |
8130105 | Al-Ali et al. | Mar 2012 | B2 |
8145287 | Diab et al. | Mar 2012 | B2 |
8150487 | Diab et al. | Apr 2012 | B2 |
8175672 | Parker | May 2012 | B2 |
8180420 | Diab et al. | May 2012 | B2 |
8182443 | Kiani | May 2012 | B1 |
8185180 | Diab et al. | May 2012 | B2 |
8190223 | Al-Ali et al. | May 2012 | B2 |
8190227 | Diab et al. | May 2012 | B2 |
8203438 | Kiani et al. | Jun 2012 | B2 |
8203704 | Merritt et al. | Jun 2012 | B2 |
8204566 | Schurman et al. | Jun 2012 | B2 |
8219172 | Schurman et al. | Jul 2012 | B2 |
8224411 | Al-Ali et al. | Jul 2012 | B2 |
8228181 | Al-Ali | Jul 2012 | B2 |
8229533 | Diab et al. | Jul 2012 | B2 |
8233955 | Al-Ali et al. | Jul 2012 | B2 |
8244325 | Al-Ali et al. | Aug 2012 | B2 |
8251903 | LeBoeuf | Aug 2012 | B2 |
8255026 | Al-Ali | Aug 2012 | B1 |
8255027 | Al-Ali et al. | Aug 2012 | B2 |
8255028 | Al-Ali et al. | Aug 2012 | B2 |
8260577 | Weber et al. | Sep 2012 | B2 |
8265723 | McHale et al. | Sep 2012 | B1 |
8274360 | Sampath et al. | Sep 2012 | B2 |
8280473 | Al-Ali | Oct 2012 | B2 |
8290559 | Shariati | Oct 2012 | B2 |
8301217 | Al-Ali et al. | Oct 2012 | B2 |
8306596 | Schurman et al. | Nov 2012 | B2 |
8310336 | Muhsin et al. | Nov 2012 | B2 |
8315683 | Al-Ali et al. | Nov 2012 | B2 |
RE43860 | Parker | Dec 2012 | E |
8337403 | Al-Ali et al. | Dec 2012 | B2 |
8346330 | Lamego | Jan 2013 | B2 |
8353842 | Al-Ali et al. | Jan 2013 | B2 |
8355766 | MacNeish, III et al. | Jan 2013 | B2 |
8359080 | Diab et al. | Jan 2013 | B2 |
8364223 | Al-Ali et al. | Jan 2013 | B2 |
8364226 | Diab et al. | Jan 2013 | B2 |
8374665 | Lamego | Feb 2013 | B2 |
8385995 | Al-ali et al. | Feb 2013 | B2 |
8385996 | Smith et al. | Feb 2013 | B2 |
8388353 | Kiani et al. | Mar 2013 | B2 |
8399822 | Al-Ali | Mar 2013 | B2 |
8401602 | Kiani | Mar 2013 | B2 |
8405608 | Al-Ali et al. | Mar 2013 | B2 |
8414499 | Al-Ali et al. | Apr 2013 | B2 |
8418524 | Al-Ali | Apr 2013 | B2 |
8423106 | Lamego et al. | Apr 2013 | B2 |
8428967 | Olsen et al. | Apr 2013 | B2 |
8430817 | Al-Ali et al. | Apr 2013 | B1 |
8437825 | Dalvi et al. | May 2013 | B2 |
8455290 | Siskavich | Jun 2013 | B2 |
8457703 | Al-Ali | Jun 2013 | B2 |
8457707 | Kiani | Jun 2013 | B2 |
8463349 | Diab et al. | Jun 2013 | B2 |
8466286 | Bellot et al. | Jun 2013 | B2 |
8471713 | Poeze et al. | Jun 2013 | B2 |
8473020 | Kiani et al. | Jun 2013 | B2 |
8483787 | Al-Ali et al. | Jul 2013 | B2 |
8489364 | Weber et al. | Jul 2013 | B2 |
8498684 | Weber et al. | Jul 2013 | B2 |
8504128 | Blank et al. | Aug 2013 | B2 |
8509867 | Workman et al. | Aug 2013 | B2 |
8515509 | Bruinsma et al. | Aug 2013 | B2 |
8523781 | Al-Ali | Sep 2013 | B2 |
8529301 | Al-Ali et al. | Sep 2013 | B2 |
8532727 | Ali et al. | Sep 2013 | B2 |
8532728 | Diab et al. | Sep 2013 | B2 |
D692145 | Al-Ali et al. | Oct 2013 | S |
8547209 | Kiani et al. | Oct 2013 | B2 |
8548548 | Al-Ali | Oct 2013 | B2 |
8548549 | Schurman et al. | Oct 2013 | B2 |
8548550 | Al-Ali et al. | Oct 2013 | B2 |
8560032 | Al-Ali et al. | Oct 2013 | B2 |
8560034 | Diab et al. | Oct 2013 | B1 |
8570167 | Al-Ali | Oct 2013 | B2 |
8570503 | Vo et al. | Oct 2013 | B2 |
8571617 | Reichgott et al. | Oct 2013 | B2 |
8571618 | Lamego et al. | Oct 2013 | B1 |
8571619 | Al-Ali et al. | Oct 2013 | B2 |
8584345 | Al-Ali et al. | Oct 2013 | B2 |
8577431 | Lamego et al. | Nov 2013 | B2 |
8581732 | Al-Ali et al. | Nov 2013 | B2 |
8588880 | Abdul-Hafiz et al. | Nov 2013 | B2 |
8600467 | Al-Ali et al. | Dec 2013 | B2 |
8606342 | Diab | Dec 2013 | B2 |
8626255 | Al-Ali et al. | Jan 2014 | B2 |
8630691 | Lamego et al. | Jan 2014 | B2 |
8634889 | Al-Ali et al. | Jan 2014 | B2 |
8641631 | Sierra et al. | Feb 2014 | B2 |
8652060 | Al-Ali | Feb 2014 | B2 |
8663107 | Kiani | Mar 2014 | B2 |
8666468 | Al-Ali | Mar 2014 | B1 |
8667967 | Al-Ali et al. | Mar 2014 | B2 |
8670811 | O'Reilly | Mar 2014 | B2 |
8670814 | Diab et al. | Mar 2014 | B2 |
8676286 | Weber et al. | Mar 2014 | B2 |
8682407 | Al-Ali | Mar 2014 | B2 |
RE44823 | Parker | Apr 2014 | E |
RE44875 | Kiani et al. | Apr 2014 | E |
8690799 | Telfort et al. | Apr 2014 | B2 |
8700112 | Kiani | Apr 2014 | B2 |
8702627 | Telfort et al. | Apr 2014 | B2 |
8706179 | Parker | Apr 2014 | B2 |
8712494 | MacNeish, III et al. | Apr 2014 | B1 |
8715206 | Telfort et al. | May 2014 | B2 |
8718735 | Lamego et al. | May 2014 | B2 |
8718737 | Diab et al. | May 2014 | B2 |
8718738 | Blank et al. | May 2014 | B2 |
8720249 | Al-Ali | May 2014 | B2 |
8721541 | Al-Ali et al. | May 2014 | B2 |
8721542 | Al-Ali et al. | May 2014 | B2 |
8723677 | Kiani | May 2014 | B1 |
8740792 | Kiani et al. | Jun 2014 | B1 |
8754776 | Poeze et al. | Jun 2014 | B2 |
8755535 | Telfort et al. | Jun 2014 | B2 |
8755856 | Diab et al. | Jun 2014 | B2 |
8755872 | Marinow | Jun 2014 | B1 |
8761850 | Lamego | Jun 2014 | B2 |
8764671 | Kiani | Jul 2014 | B2 |
8768423 | Shakespeare et al. | Jul 2014 | B2 |
8771204 | Telfort et al. | Jul 2014 | B2 |
8777634 | Kiani et al. | Jul 2014 | B2 |
8781543 | Diab et al. | Jul 2014 | B2 |
8781544 | Al-Ali et al. | Jul 2014 | B2 |
8781549 | Al-Ali et al. | Jul 2014 | B2 |
8788003 | Schurman et al. | Jul 2014 | B2 |
8790268 | Al-Ali | Jul 2014 | B2 |
8801613 | Al-Ali et al. | Aug 2014 | B2 |
8821397 | Al-Ali et al. | Sep 2014 | B2 |
8821415 | Al-Ali et al. | Sep 2014 | B2 |
8830449 | Lamego et al. | Sep 2014 | B1 |
8831700 | Schurman et al. | Sep 2014 | B2 |
8840549 | Al-Ali et al. | Sep 2014 | B2 |
8847740 | Kiani et al. | Sep 2014 | B2 |
8849365 | Smith et al. | Sep 2014 | B2 |
8852094 | Al-Ali et al. | Oct 2014 | B2 |
8852994 | Wojtczuk et al. | Oct 2014 | B2 |
8868147 | Stippick et al. | Oct 2014 | B2 |
8868150 | Al-Ali et al. | Oct 2014 | B2 |
8870792 | Al-Ali et al. | Oct 2014 | B2 |
8886271 | Kiani et al. | Nov 2014 | B2 |
8888539 | Al-Ali et al. | Nov 2014 | B2 |
8888708 | Diab et al. | Nov 2014 | B2 |
8892180 | Weber et al. | Nov 2014 | B2 |
8897847 | Al-Ali | Nov 2014 | B2 |
8909310 | Lamego et al. | Dec 2014 | B2 |
8911377 | Al-Ali | Dec 2014 | B2 |
8912909 | Al-Ali et al. | Dec 2014 | B2 |
8920317 | Al-Ali et al. | Dec 2014 | B2 |
8921699 | Al-Ali et al. | Dec 2014 | B2 |
8922382 | Al-Ali et al. | Dec 2014 | B2 |
8929964 | Al-Ali et al. | Jan 2015 | B2 |
8942777 | Diab et al. | Jan 2015 | B2 |
8948834 | Diab et al. | Feb 2015 | B2 |
8948835 | Diab | Feb 2015 | B2 |
8961415 | LeBoeuf | Feb 2015 | B2 |
8965471 | Lamego | Feb 2015 | B2 |
8983564 | Al-Ali | Mar 2015 | B2 |
8989831 | Al-Ali et al. | Mar 2015 | B2 |
8996085 | Kiani et al. | Mar 2015 | B2 |
8998809 | Kiani | Apr 2015 | B2 |
9028429 | Telfort et al. | May 2015 | B2 |
9037207 | Al-Ali et al. | May 2015 | B2 |
9060721 | Reichgott et al. | Jun 2015 | B2 |
9066666 | Kiani | Jun 2015 | B2 |
9066680 | Al-Ali et al. | Jun 2015 | B1 |
9072474 | Al-Ali et al. | Jul 2015 | B2 |
9078560 | Schurman et al. | Jul 2015 | B2 |
9084569 | Weber et al. | Jul 2015 | B2 |
9095316 | Welch et al. | Aug 2015 | B2 |
9106038 | Telfort et al. | Aug 2015 | B2 |
9107625 | Telfort et al. | Aug 2015 | B2 |
9107626 | Al-Ali et al. | Aug 2015 | B2 |
9113831 | Al-Ali | Aug 2015 | B2 |
9113832 | Al-Ali | Aug 2015 | B2 |
9119595 | Lamego | Sep 2015 | B2 |
9131881 | Diab et al. | Sep 2015 | B2 |
9131882 | Al-Ali et al. | Sep 2015 | B2 |
9131883 | Al-Ali | Sep 2015 | B2 |
9131917 | Telfort et al. | Sep 2015 | B2 |
9138180 | Coverston et al. | Sep 2015 | B1 |
9138182 | Al-Ali et al. | Sep 2015 | B2 |
9138192 | Weber et al. | Sep 2015 | B2 |
9142117 | Muhsin et al. | Sep 2015 | B2 |
9153112 | Kiani et al. | Oct 2015 | B1 |
9153121 | Kiani et al. | Oct 2015 | B2 |
9161696 | Al-Ali et al. | Oct 2015 | B2 |
9161713 | Al-Ali et al. | Oct 2015 | B2 |
9167995 | Lamego et al. | Oct 2015 | B2 |
9176141 | Al-Ali et al. | Nov 2015 | B2 |
9186102 | Bruinsma et al. | Nov 2015 | B2 |
9192312 | Al-Ali | Nov 2015 | B2 |
9192329 | Al-Ali | Nov 2015 | B2 |
9192351 | Telfort et al. | Nov 2015 | B1 |
9195385 | Al-Ali et al. | Nov 2015 | B2 |
9211072 | Kiani | Dec 2015 | B2 |
9211095 | Al-Ali | Dec 2015 | B1 |
9218454 | Kiani et al. | Dec 2015 | B2 |
9220409 | Lisogurski | Dec 2015 | B2 |
9226696 | Kiani | Jan 2016 | B2 |
9241662 | Al-Ali et al. | Jan 2016 | B2 |
9245668 | Vo et al. | Jan 2016 | B1 |
9259185 | Abdul-Hafiz et al. | Feb 2016 | B2 |
9267572 | Barker et al. | Feb 2016 | B2 |
9277880 | Poeze et al. | Mar 2016 | B2 |
9289167 | Diab et al. | Mar 2016 | B2 |
9295421 | Kiani et al. | Mar 2016 | B2 |
9307928 | Al-Ali et al. | Apr 2016 | B1 |
9323894 | Kiani | Apr 2016 | B2 |
D755392 | Hwang et al. | May 2016 | S |
9326712 | Kiani | May 2016 | B1 |
9333316 | Kiani | May 2016 | B2 |
9339220 | Lamego et al. | May 2016 | B2 |
9341565 | Lamego et al. | May 2016 | B2 |
9351673 | Diab et al. | May 2016 | B2 |
9351675 | Al-Ali et al. | May 2016 | B2 |
9364181 | Kiani et al. | Jun 2016 | B2 |
9368671 | Wojtczuk et al. | Jun 2016 | B2 |
9370325 | Al-Ali et al. | Jun 2016 | B2 |
9370326 | McHale et al. | Jun 2016 | B2 |
9370335 | Al-Ali et al. | Jun 2016 | B2 |
9375185 | Ali et al. | Jun 2016 | B2 |
9386953 | Al-Ali | Jul 2016 | B2 |
9386961 | Al-Ali et al. | Jul 2016 | B2 |
9392945 | Al-Ali et al. | Jul 2016 | B2 |
9397448 | Al-Ali et al. | Jul 2016 | B2 |
9408542 | Kinast et al. | Aug 2016 | B1 |
9436645 | Al-Ali et al. | Sep 2016 | B2 |
9445759 | Lamego et al. | Sep 2016 | B1 |
9466919 | Kiani et al. | Oct 2016 | B2 |
9474474 | Lamego et al. | Oct 2016 | B2 |
9480422 | Al-Ali | Nov 2016 | B2 |
9480435 | Olsen | Nov 2016 | B2 |
9492110 | Al-Ali et al. | Nov 2016 | B2 |
9510779 | Poeze et al. | Dec 2016 | B2 |
9517024 | Kiani et al. | Dec 2016 | B2 |
9532722 | Lamego et al. | Jan 2017 | B2 |
9538949 | Al-Ali et al. | Jan 2017 | B2 |
9538980 | Telfort et al. | Jan 2017 | B2 |
9549696 | Lamego et al. | Jan 2017 | B2 |
9554737 | Schurman et al. | Jan 2017 | B2 |
9560996 | Kiani | Feb 2017 | B2 |
9560998 | Al-Ali et al. | Feb 2017 | B2 |
9566019 | Al-Ali et al. | Feb 2017 | B2 |
9579039 | Jansen et al. | Feb 2017 | B2 |
9591975 | Dalvi et al. | Mar 2017 | B2 |
9622692 | Lamego et al. | Apr 2017 | B2 |
9622693 | Diab | Apr 2017 | B2 |
D788312 | Al-Ali et al. | May 2017 | S |
9636055 | Al-Ali et al. | May 2017 | B2 |
9636056 | Al-Ali | May 2017 | B2 |
9649054 | Lamego et al. | May 2017 | B2 |
9662052 | Al-Ali et al. | May 2017 | B2 |
9668679 | Schurman et al. | Jun 2017 | B2 |
9668680 | Bruinsma et al. | Jun 2017 | B2 |
9668703 | Al-Ali | Jun 2017 | B2 |
9675286 | Diab | Jun 2017 | B2 |
9687160 | Kiani | Jun 2017 | B2 |
9693719 | Al-Ali et al. | Jul 2017 | B2 |
9693737 | Al-Ali | Jul 2017 | B2 |
9697928 | Al-Ali et al. | Jul 2017 | B2 |
9717425 | Kiani et al. | Aug 2017 | B2 |
9717458 | Lamego et al. | Aug 2017 | B2 |
9724016 | Al-Ali et al. | Aug 2017 | B1 |
9724024 | Al-Ali | Aug 2017 | B2 |
9724025 | Kiani et al. | Aug 2017 | B1 |
9730640 | Diab et al. | Aug 2017 | B2 |
9743887 | Al-Ali et al. | Aug 2017 | B2 |
9749232 | Sampath et al. | Aug 2017 | B2 |
9750442 | Olsen | Sep 2017 | B2 |
9750443 | Smith et al. | Sep 2017 | B2 |
9750461 | Telfort | Sep 2017 | B1 |
9775545 | Al-Ali et al. | Oct 2017 | B2 |
9775546 | Diab et al. | Oct 2017 | B2 |
9775570 | Al-Ali | Oct 2017 | B2 |
9778079 | Al-Ali et al. | Oct 2017 | B1 |
9782077 | Lamego et al. | Oct 2017 | B2 |
9782110 | Kiani | Oct 2017 | B2 |
9787568 | Lamego et al. | Oct 2017 | B2 |
9788735 | Al-Ali | Oct 2017 | B2 |
9788768 | Al-Ali et al. | Oct 2017 | B2 |
9795300 | Al-Ali | Oct 2017 | B2 |
9795310 | Al-Ali | Oct 2017 | B2 |
9795358 | Telfort et al. | Oct 2017 | B2 |
9795739 | Al-Ali et al. | Oct 2017 | B2 |
9801556 | Kiani | Oct 2017 | B2 |
9801588 | Weber et al. | Oct 2017 | B2 |
9808188 | Perea et al. | Nov 2017 | B1 |
9814418 | Weber et al. | Nov 2017 | B2 |
9820691 | Kiani | Nov 2017 | B2 |
9833152 | Kiani et al. | Dec 2017 | B2 |
9833180 | Shakespeare et al. | Dec 2017 | B2 |
9839379 | Al-Ali et al. | Dec 2017 | B2 |
9839381 | Weber et al. | Dec 2017 | B1 |
9847002 | Kiani et al. | Dec 2017 | B2 |
9847749 | Kiani et al. | Dec 2017 | B2 |
9848800 | Lee et al. | Dec 2017 | B1 |
9848806 | Al-Ali et al. | Dec 2017 | B2 |
9848807 | Lamego | Dec 2017 | B2 |
9861298 | Eckerbom et al. | Jan 2018 | B2 |
9861304 | Al-Ali et al. | Jan 2018 | B2 |
9861305 | Weber et al. | Jan 2018 | B1 |
9867578 | Al-Ali et al. | Jan 2018 | B2 |
9872623 | Al-Ali | Jan 2018 | B2 |
9876320 | Coverston et al. | Jan 2018 | B2 |
9877650 | Muhsin et al. | Jan 2018 | B2 |
9877686 | Al-Ali et al. | Jan 2018 | B2 |
9891079 | Dalvi | Feb 2018 | B2 |
9895107 | Al-Ali et al. | Feb 2018 | B2 |
9913617 | Al-Ali et al. | Mar 2018 | B2 |
9924893 | Schurman et al. | Mar 2018 | B2 |
9924897 | Abdul-Hafiz | Mar 2018 | B1 |
9936917 | Poeze et al. | Apr 2018 | B2 |
9943269 | Muhsin et al. | Apr 2018 | B2 |
9949676 | Al-Ali | Apr 2018 | B2 |
9955937 | Telfort | May 2018 | B2 |
9965946 | Al-Ali | May 2018 | B2 |
9980667 | Kiani et al. | May 2018 | B2 |
D820865 | Muhsin et al. | Jun 2018 | S |
9986919 | Lamego et al. | Jun 2018 | B2 |
9986952 | Dalvi et al. | Jun 2018 | B2 |
9989560 | Poeze et al. | Jun 2018 | B2 |
9993207 | Al-Ali et al. | Jun 2018 | B2 |
10007758 | Al-Ali et al. | Jun 2018 | B2 |
D822215 | Al-Ali et al. | Jul 2018 | S |
D822216 | Barker et al. | Jul 2018 | S |
10010276 | Al-Ali et al. | Jul 2018 | B2 |
10032002 | Kiani et al. | Jul 2018 | B2 |
10039482 | Al-Ali et al. | Aug 2018 | B2 |
10052037 | Kinast et al. | Aug 2018 | B2 |
10058275 | Al-Ali et al. | Aug 2018 | B2 |
10064562 | Al-Ali | Sep 2018 | B2 |
10076282 | LeBoeuf | Sep 2018 | B2 |
10086138 | Novak, Jr. | Oct 2018 | B1 |
10092200 | Al-Ali et al. | Oct 2018 | B2 |
10092249 | Kiani et al. | Oct 2018 | B2 |
10098550 | Al-Ali et al. | Oct 2018 | B2 |
10098591 | Al-Ali et al. | Oct 2018 | B2 |
10098610 | Al-Ali et al. | Oct 2018 | B2 |
10366787 | Sampath | Jul 2019 | B2 |
10456038 | Lamego | Oct 2019 | B2 |
10503379 | Al-Ali | Dec 2019 | B2 |
10729402 | Al-Ali | Aug 2020 | B2 |
20060074321 | Kouchi et al. | Apr 2006 | A1 |
20060161054 | Reuss et al. | Jul 2006 | A1 |
20070043269 | Mannheimer | Feb 2007 | A1 |
20070282478 | Al-Ali et al. | Dec 2007 | A1 |
20080146892 | LeBoeuf | Jun 2008 | A1 |
20090043446 | Drew et al. | Feb 2009 | A1 |
20090046096 | Rampersad | Feb 2009 | A1 |
20090054743 | Stewart | Feb 2009 | A1 |
20090171167 | Baker, Jr. | Jul 2009 | A1 |
20090247984 | Lamego et al. | Oct 2009 | A1 |
20090259114 | Johnson | Oct 2009 | A1 |
20090275813 | Davis | Nov 2009 | A1 |
20090275844 | Al-Ali | Nov 2009 | A1 |
20100004518 | Vo et al. | Jan 2010 | A1 |
20100004519 | Lamego | Jan 2010 | A1 |
20100030040 | Poeze et al. | Feb 2010 | A1 |
20100261979 | Kiani | Oct 2010 | A1 |
20110001605 | Kiani et al. | Jan 2011 | A1 |
20110082711 | Poeze et al. | Apr 2011 | A1 |
20110087083 | Poeze et al. | Apr 2011 | A1 |
20110105854 | Kiani et al. | May 2011 | A1 |
20110125060 | Telfort et al. | May 2011 | A1 |
20110208015 | Welch et al. | Aug 2011 | A1 |
20110213212 | Al-Ali | Sep 2011 | A1 |
20110227927 | Garmon et al. | Sep 2011 | A1 |
20110230733 | Al-Ali | Sep 2011 | A1 |
20110237911 | Lamego et al. | Sep 2011 | A1 |
20110237969 | Eckerbom et al. | Sep 2011 | A1 |
20110288383 | Diab | Nov 2011 | A1 |
20120041316 | Al-Ali et al. | Feb 2012 | A1 |
20120046557 | Kiani | Feb 2012 | A1 |
20120059267 | Lamego et al. | Mar 2012 | A1 |
20120088984 | Al-Ali et al. | Apr 2012 | A1 |
20120116175 | Al-Ali et al. | May 2012 | A1 |
20120165629 | Merritt et al. | Jun 2012 | A1 |
20120179006 | Jansen et al. | Jul 2012 | A1 |
20120209082 | Al-Ali | Aug 2012 | A1 |
20120209084 | Olsen et al. | Aug 2012 | A1 |
20120226117 | Lamego | Sep 2012 | A1 |
20120227739 | Kiani | Sep 2012 | A1 |
20120283524 | Kiani et al. | Nov 2012 | A1 |
20120296178 | Lamego et al. | Nov 2012 | A1 |
20120319816 | Al-Ali | Dec 2012 | A1 |
20120330112 | Lamego et al. | Dec 2012 | A1 |
20130023775 | Lamego et al. | Jan 2013 | A1 |
20130045685 | Kiani | Feb 2013 | A1 |
20130046204 | Lamego et al. | Feb 2013 | A1 |
20130041591 | Lamego | Mar 2013 | A1 |
20130060147 | Welch et al. | Mar 2013 | A1 |
20130096405 | Garfio | Apr 2013 | A1 |
20130096936 | Sampath et al. | Apr 2013 | A1 |
20130109935 | Al-Ali et al. | May 2013 | A1 |
20130162433 | Muhsin et al. | Jun 2013 | A1 |
20130190581 | Al-Ali et al. | Jul 2013 | A1 |
20130197328 | Diab et al. | Aug 2013 | A1 |
20130211214 | Olsen | Aug 2013 | A1 |
20130243021 | Siskavich | Sep 2013 | A1 |
20130253334 | Al-Ali et al. | Sep 2013 | A1 |
20130254717 | Al-Ali | Sep 2013 | A1 |
20130262730 | Al-Ali et al. | Oct 2013 | A1 |
20130267804 | Al-Ali | Oct 2013 | A1 |
20130274571 | Diab et al. | Oct 2013 | A1 |
20130274572 | Al-Ali et al. | Oct 2013 | A1 |
20130296672 | O'Neil et al. | Nov 2013 | A1 |
20130296713 | Al-Ali et al. | Nov 2013 | A1 |
20130317370 | Dalvi et al. | Nov 2013 | A1 |
20130324808 | Al-Ali et al. | Dec 2013 | A1 |
20130331660 | Al-Ali et al. | Dec 2013 | A1 |
20130331670 | Kiani | Dec 2013 | A1 |
20130338461 | Lamego et al. | Dec 2013 | A1 |
20140012100 | Al-Ali et al. | Jan 2014 | A1 |
20140025306 | Weber et al. | Jan 2014 | A1 |
20140034353 | Al-Ali et al. | Feb 2014 | A1 |
20140051953 | Lamego et al. | Feb 2014 | A1 |
20140058230 | Abdul-Hafiz et al. | Feb 2014 | A1 |
20140066783 | Kiani et al. | Mar 2014 | A1 |
20140077956 | Sampath et al. | Mar 2014 | A1 |
20140081100 | Muhsin et al. | Mar 2014 | A1 |
20140081175 | Telfort | Mar 2014 | A1 |
20140094667 | Schurman et al. | Apr 2014 | A1 |
20140100434 | Diab et al. | Apr 2014 | A1 |
20140114199 | Lamego et al. | Apr 2014 | A1 |
20140120564 | Workman et al. | May 2014 | A1 |
20140121482 | Merritt et al. | May 2014 | A1 |
20140121483 | Kiani | May 2014 | A1 |
20140127137 | Bellott et al. | May 2014 | A1 |
20140128696 | Al-Ali | May 2014 | A1 |
20140128699 | Al-Ali et al. | May 2014 | A1 |
20140129702 | Lamego et al. | May 2014 | A1 |
20140135588 | Al-Ali et al. | May 2014 | A1 |
20140142401 | Al-Ali et al. | May 2014 | A1 |
20140142402 | Al-Ali et al. | May 2014 | A1 |
20140163344 | Al-Ali | Jun 2014 | A1 |
20140163402 | Lamego et al. | Jun 2014 | A1 |
20140166076 | Kiani et al. | Jun 2014 | A1 |
20140171763 | Diab | Jun 2014 | A1 |
20140180038 | Kiani | Jun 2014 | A1 |
20140180154 | Sierra et al. | Jun 2014 | A1 |
20140180160 | Brown et al. | Jun 2014 | A1 |
20140187973 | Brown et al. | Jul 2014 | A1 |
20140194709 | Al-Ali et al. | Jul 2014 | A1 |
20140194711 | Al-Ali | Jul 2014 | A1 |
20140194766 | Al-Ali et al. | Jul 2014 | A1 |
20140206963 | Al-Ali | Jul 2014 | A1 |
20140213864 | Abdul-Hafiz et al. | Jul 2014 | A1 |
20140243627 | Diab et al. | Aug 2014 | A1 |
20140266790 | Al-Ali et al. | Sep 2014 | A1 |
20140275808 | Poeze et al. | Sep 2014 | A1 |
20140275835 | Lamego et al. | Sep 2014 | A1 |
20140275871 | Lamego et al. | Sep 2014 | A1 |
20140275872 | Merritt et al. | Sep 2014 | A1 |
20140275881 | Lamego et al. | Sep 2014 | A1 |
20140276115 | Dalvi et al. | Sep 2014 | A1 |
20140288400 | Diab et al. | Sep 2014 | A1 |
20140296664 | Bruinsma et al. | Oct 2014 | A1 |
20140303520 | Telfort et al. | Oct 2014 | A1 |
20140309506 | Lamego et al. | Oct 2014 | A1 |
20140316217 | Purdon et al. | Oct 2014 | A1 |
20140316218 | Purdon et al. | Oct 2014 | A1 |
20140316228 | Blank et al. | Oct 2014 | A1 |
20140323825 | Al-Ali et al. | Oct 2014 | A1 |
20140323897 | Brown et al. | Oct 2014 | A1 |
20140323898 | Purdon et al. | Oct 2014 | A1 |
20140330092 | Al-Ali et al. | Nov 2014 | A1 |
20140330098 | Merritt et al. | Nov 2014 | A1 |
20140330099 | Al-Ali et al. | Nov 2014 | A1 |
20140333440 | Kiani | Nov 2014 | A1 |
20140336481 | Shakespeare et al. | Nov 2014 | A1 |
20140343436 | Kiani | Nov 2014 | A1 |
20140357966 | Al-Ali et al. | Dec 2014 | A1 |
20140371548 | Al-Ali et al. | Dec 2014 | A1 |
20140378784 | Kiani et al. | Dec 2014 | A1 |
20150005600 | Blank et al. | Jan 2015 | A1 |
20150011907 | Purdon et al. | Jan 2015 | A1 |
20150012231 | Poeze et al. | Jan 2015 | A1 |
20150018650 | Al-Ali et al. | Jan 2015 | A1 |
20150025406 | Al-Ali | Jan 2015 | A1 |
20150032029 | Al-Ali et al. | Jan 2015 | A1 |
20150038859 | Dalvi et al. | Feb 2015 | A1 |
20150045637 | Dalvi | Feb 2015 | A1 |
20150051462 | Olsen | Feb 2015 | A1 |
20150080754 | Purdon et al. | Mar 2015 | A1 |
20150087936 | Al-Ali et al. | Mar 2015 | A1 |
20150094546 | Al-Ali | Apr 2015 | A1 |
20150097701 | Al-Ali et al. | Apr 2015 | A1 |
20150099950 | Al-Ali et al. | Apr 2015 | A1 |
20150099951 | Al-Ali et al. | Apr 2015 | A1 |
20150099955 | Al-Ali et al. | Apr 2015 | A1 |
20150101844 | Al-Ali et al. | Apr 2015 | A1 |
20150106121 | Muhsin et al. | Apr 2015 | A1 |
20150112151 | Muhsin et al. | Apr 2015 | A1 |
20150116076 | Al-Ali et al. | Apr 2015 | A1 |
20150126830 | Schurman et al. | May 2015 | A1 |
20150133755 | Smith et al. | May 2015 | A1 |
20150141781 | Weber et al. | May 2015 | A1 |
20150165312 | Kiani | Jun 2015 | A1 |
20150196237 | Lamego | Jul 2015 | A1 |
20150196249 | Brown et al. | Jul 2015 | A1 |
20150201874 | Diab | Jul 2015 | A1 |
20150208966 | Al-Ali | Jul 2015 | A1 |
20150216459 | Al-Ali et al. | Aug 2015 | A1 |
20150230755 | Al-Ali et al. | Aug 2015 | A1 |
20150238722 | Al-Ali | Aug 2015 | A1 |
20150245773 | Lamego et al. | Sep 2015 | A1 |
20150245794 | Al-Ali | Sep 2015 | A1 |
20150257689 | Al-Ali et al. | Sep 2015 | A1 |
20150272514 | Kiani et al. | Oct 2015 | A1 |
20150351697 | Weber et al. | Dec 2015 | A1 |
20150351704 | Kiani et al. | Dec 2015 | A1 |
20150359429 | Al-Ali et al. | Dec 2015 | A1 |
20150366472 | Kiani | Dec 2015 | A1 |
20150366507 | Blank | Dec 2015 | A1 |
20150374298 | Al-Ali et al. | Dec 2015 | A1 |
20150380875 | Coverston et al. | Dec 2015 | A1 |
20160000362 | Diab et al. | Jan 2016 | A1 |
20160007930 | Weber et al. | Jan 2016 | A1 |
20160029932 | Al-Ali | Feb 2016 | A1 |
20160029933 | Al-Ali et al. | Feb 2016 | A1 |
20160045118 | Kiani | Feb 2016 | A1 |
20160051205 | Al-Ali et al. | Feb 2016 | A1 |
20160058338 | Schurman et al. | Mar 2016 | A1 |
20160058347 | Reichgott et al. | Mar 2016 | A1 |
20160066823 | Kind et al. | Mar 2016 | A1 |
20160066824 | Al-Ali et al. | Mar 2016 | A1 |
20160066879 | Telfort et al. | Mar 2016 | A1 |
20160072429 | Kiani et al. | Mar 2016 | A1 |
20160081552 | Wojtczuk et al. | Mar 2016 | A1 |
20160095543 | Telfort et al. | Apr 2016 | A1 |
20160095548 | Al-Ali et al. | Apr 2016 | A1 |
20160103598 | Al-Ali et al. | Apr 2016 | A1 |
20160113527 | Al-Ali et al. | Apr 2016 | A1 |
20160143548 | Al-Ali | May 2016 | A1 |
20160166182 | Al-Ali et al. | Jun 2016 | A1 |
20160166183 | Poeze et al. | Jun 2016 | A1 |
20160166188 | Bruinsma et al. | Jun 2016 | A1 |
20160166210 | Al-Ali | Jun 2016 | A1 |
20160192869 | Kiani et al. | Jul 2016 | A1 |
20160196388 | Lamego | Jul 2016 | A1 |
20160197436 | Barker et al. | Jul 2016 | A1 |
20160213281 | Eckerbom et al. | Jul 2016 | A1 |
20160228043 | O'Neil et al. | Aug 2016 | A1 |
20160233632 | Scruggs et al. | Aug 2016 | A1 |
20160234944 | Schmidt et al. | Aug 2016 | A1 |
20160270735 | Diab et al. | Sep 2016 | A1 |
20160283665 | Sampath et al. | Sep 2016 | A1 |
20160287090 | Al-Ali et al. | Oct 2016 | A1 |
20160287786 | Kiani | Oct 2016 | A1 |
20160296169 | McHale et al. | Oct 2016 | A1 |
20160310052 | Al-Ali et al. | Oct 2016 | A1 |
20160314260 | Kiani | Oct 2016 | A1 |
20160324486 | Al-Ali et al. | Nov 2016 | A1 |
20160324488 | Olsen | Nov 2016 | A1 |
20160327984 | Al-Ali et al. | Nov 2016 | A1 |
20160328528 | Al-Ali et al. | Nov 2016 | A1 |
20160331332 | Al-Ali | Nov 2016 | A1 |
20160367173 | Dalvi et al. | Dec 2016 | A1 |
20170007134 | Al-Ali et al. | Jan 2017 | A1 |
20170007190 | Al-Ali et al. | Jan 2017 | A1 |
20170007198 | Al-Ali et al. | Jan 2017 | A1 |
20170014083 | Diab et al. | Jan 2017 | A1 |
20170014084 | Al-Ali et al. | Jan 2017 | A1 |
20170021099 | Al-Ali et al. | Jan 2017 | A1 |
20170027456 | Kinast et al. | Feb 2017 | A1 |
20170042488 | Muhsin | Feb 2017 | A1 |
20170055851 | Al-Ali | Mar 2017 | A1 |
20170055882 | Al-Ali et al. | Mar 2017 | A1 |
20170055887 | Al-Ali | Mar 2017 | A1 |
20170055896 | Al-Ali et al. | Mar 2017 | A1 |
20170079594 | Telfort et al. | Mar 2017 | A1 |
20170086723 | Al-Ali et al. | Mar 2017 | A1 |
20170143281 | Olsen | May 2017 | A1 |
20170147774 | Kiani | May 2017 | A1 |
20170156620 | Al-Ali et al. | Jun 2017 | A1 |
20170173632 | Al-Ali | Jun 2017 | A1 |
20170187146 | Kiani et al. | Jun 2017 | A1 |
20170188919 | Al-Ali et al. | Jul 2017 | A1 |
20170196464 | Jansen et al. | Jul 2017 | A1 |
20170196470 | Lamego et al. | Jul 2017 | A1 |
20170202490 | Al-Ali et al. | Jul 2017 | A1 |
20170224262 | Al-Ali | Aug 2017 | A1 |
20170228516 | Sampath et al. | Aug 2017 | A1 |
20170245790 | Al-Ali et al. | Aug 2017 | A1 |
20170251974 | Shreim et al. | Sep 2017 | A1 |
20170251975 | Shreim et al. | Sep 2017 | A1 |
20170258403 | Abdul-Hafiz et al. | Sep 2017 | A1 |
20170311851 | Schurman et al. | Nov 2017 | A1 |
20170311891 | Kiani et al. | Nov 2017 | A1 |
20170325728 | Al-Ali et al. | Nov 2017 | A1 |
20170332976 | Al-Ali et al. | Nov 2017 | A1 |
20170340293 | Al-Ali et al. | Nov 2017 | A1 |
20170360310 | Kiani et al. | Dec 2017 | A1 |
20170367632 | Al-Ali et al. | Dec 2017 | A1 |
20180008146 | Al-Ali et al. | Jan 2018 | A1 |
20180014752 | Al-Ali et al. | Jan 2018 | A1 |
20180028124 | Al-Ali et al. | Feb 2018 | A1 |
20180055385 | Al-Ali | Mar 2018 | A1 |
20180055390 | Kiani et al. | Mar 2018 | A1 |
20180055430 | Diab et al. | Mar 2018 | A1 |
20180064381 | Shakespeare et al. | Mar 2018 | A1 |
20180069776 | Lamego et al. | Mar 2018 | A1 |
20180070867 | Smith et al. | Mar 2018 | A1 |
20180082767 | Al-Ali et al. | Mar 2018 | A1 |
20180085068 | Telfort | Mar 2018 | A1 |
20180087937 | Al-Ali et al. | Mar 2018 | A1 |
20180103874 | Lee et al. | Apr 2018 | A1 |
20180103905 | Kiani | Apr 2018 | A1 |
20180110478 | Al-Ali | Apr 2018 | A1 |
20180116575 | Perea et al. | May 2018 | A1 |
20180125368 | Lamego et al. | May 2018 | A1 |
20180125430 | Al-Ali et al. | May 2018 | A1 |
20180125445 | Telfort et al. | May 2018 | A1 |
20180130325 | Kiani et al. | May 2018 | A1 |
20180132769 | Weber et al. | May 2018 | A1 |
20180132770 | Lamego | May 2018 | A1 |
20180146901 | Al-Ali et al. | May 2018 | A1 |
20180146902 | Kiani et al. | May 2018 | A1 |
20180153442 | Eckerbom et al. | Jun 2018 | A1 |
20180153446 | Kiani | Jun 2018 | A1 |
20180153447 | Al-Ali et al. | Jun 2018 | A1 |
20180153448 | Weber et al. | Jun 2018 | A1 |
20180161499 | Al-Ali et al. | Jun 2018 | A1 |
20180168491 | Al-Ali et al. | Jun 2018 | A1 |
20180174679 | Sampath et al. | Jun 2018 | A1 |
20180174680 | Sampath et al. | Jun 2018 | A1 |
20180182484 | Sampath et al. | Jun 2018 | A1 |
20180184917 | Kiani | Jul 2018 | A1 |
20180192953 | Shreim et al. | Jul 2018 | A1 |
20180192955 | Al-Ali et al. | Jul 2018 | A1 |
20180199871 | Pauley et al. | Jul 2018 | A1 |
20180206795 | Al-Ali | Jul 2018 | A1 |
20180206815 | Telfort | Jul 2018 | A1 |
20180213583 | Al-Ali | Jul 2018 | A1 |
20180214031 | Kiani et al. | Aug 2018 | A1 |
20180214090 | Al-Ali et al. | Aug 2018 | A1 |
20180218792 | Muhsin et al. | Aug 2018 | A1 |
20180225960 | Al-Ali et al. | Aug 2018 | A1 |
20180238718 | Dalvi | Aug 2018 | A1 |
20180242853 | Al-Ali | Aug 2018 | A1 |
20180242921 | Muhsin et al. | Aug 2018 | A1 |
20180242926 | Muhsin et al. | Aug 2018 | A1 |
20180247353 | Al-Ali et al. | Aug 2018 | A1 |
20180247712 | Muhsin et al. | Aug 2018 | A1 |
20180249933 | Schurman et al. | Sep 2018 | A1 |
20180253947 | Muhsin et al. | Sep 2018 | A1 |
20180256087 | Al-Ali et al. | Sep 2018 | A1 |
20180256113 | Weber et al. | Sep 2018 | A1 |
20180285094 | Housel et al. | Oct 2018 | A1 |
20180289325 | Poeze et al. | Oct 2018 | A1 |
20180289337 | Al-Ali et al. | Oct 2018 | A1 |
20180296161 | Shreim et al. | Oct 2018 | A1 |
20180300919 | Muhsin et al. | Oct 2018 | A1 |
20180310822 | Indorf et al. | Nov 2018 | A1 |
20180310823 | Al-Ali et al. | Nov 2018 | A1 |
20190029578 | Al-Ali | Jan 2019 | A1 |
20190142283 | Lamego | May 2019 | A1 |
Entry |
---|
US 8,845,543 B2, 09/2014, Diab et al. (withdrawn) |
MVP-50P Overview, http://web.archive.org/web/20090422043625/http://www.buy-ei.com/Pages/MVP/MVP-50P_Overview.html, archived Apr. 22, 2009. |
BMI Scale, “How to Translate BMI into Pounds: Finally, a Body Mass Index Calculator for the Rest of Us”, http://web.archive.org/web/20080620122802/http://www.prweb.com/releases/2005/07/prweb262133.htm, archived on Jun. 20, 2008. |
MVP-50P Instrument Marking Requirements for Certified Aircraft, http://web.archive.org/web/20090306210759/http://www.buy-ei.com/Information/Redlines_Limits_MVP.pdf, archived on Mar. 6, 2009. |
Excel Univariate, http://web.archive.org/web/20090228103558/http://cameron.econ.ucdavis.edu/excel/exl lhistogram.html, archived on Feb. 29, 2009. |
Number | Date | Country | |
---|---|---|---|
20180087937 A1 | Mar 2018 | US |
Number | Date | Country | |
---|---|---|---|
61552427 | Oct 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13663457 | Oct 2012 | US |
Child | 15719218 | US |